Shuiqing Hu
Overview
Explore the profile of Shuiqing Hu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
52
Citations
1205
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hu Y, Hu S, Hui G, Zhu J, Zhang X, Zhou Q, et al.
ACS Omega
. 2024 Nov;
9(46):46588-46599.
PMID: 39583667
A series of development technologies of "horizontal well plus volume fracturing" have been established to achieve an annual output of one million tons of crude oil in 7 the Mahu...
2.
Zhang D, Fang Z, Hu S, Qiu X
Carbohydr Polym
. 2024 Sep;
346:122630.
PMID: 39245498
Cellulose nanofibril (CNF) films with both high strength and high toughness are attractive for applications in energy, packaging, and flexible electronics. However, simultaneously achieving these mechanical properties remains a significant...
3.
Luo J, Tu L, Zhou C, Li G, Shi L, Hu S
Sleep Med
. 2024 May;
119:480-487.
PMID: 38795402
Background: Sodium-glucose cotransporter 2 inhibitors (SGLT2i) initially emerged as oral antidiabetic medication but were subsequently discovered to exhibit pleiotropic actions. Insomnia is a prevalent and debilitating sleep disorder. To date,...
4.
Luo J, Hu S, Liu J, Shi L, Luo L, Li W, et al.
Cell Mol Life Sci
. 2024 May;
81(1):228.
PMID: 38777955
Diabetic cardiomyopathy (DCM) is a prevalent complication of type 2 diabetes (T2D). 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 (PFKFB3) is a glycolysis regulator. However, the potential effects of PFKFB3 in the DCM remain unclear....
5.
Luo J, Shi L, Liu J, Li G, Tu L, Hu S
Front Cardiovasc Med
. 2024 May;
11:1371513.
PMID: 38725835
Objective: To investigate the causal contributions of Sodium-glucose cotransporter 2 (SGLT2) inhibition on Heart Failure (HF) and identify the circulating proteins that mediate SGLT2 inhibition's effects on HF. Methods: Applying...
6.
Han Z, Liu X, Tian Y, Shen S, Wang H, Hu S, et al.
World J Surg
. 2024 Apr;
48(1):86-96.
PMID: 38686746
Background: Low-grade appendiceal mucinous neoplasms (LAMN) are very rare, accounting for approximately 0.2%-0.5% of gastrointestinal tumors. We conducted a multicenter retrospective study to explore the impact of different surgical procedures...
7.
Shi L, Li G, Hou N, Tu L, Li J, Luo J, et al.
Eur J Pharmacol
. 2024 Apr;
976:176619.
PMID: 38679119
Aims: Sodium-glucose cotransporter 2 (SGLT2) inhibitors offer a novel therapeutic avenue for myocardial infarction (MI). However, the exact nature of this relationship and the underlying mechanisms are not fully understood....
8.
Guo P, Hu S, Liu X, He M, Li J, Ma T, et al.
J Transl Med
. 2024 Apr;
22(1):390.
PMID: 38671439
Background: The progression of diabetic cardiomyopathy (DCM) is noticeably influenced by mitochondrial dysfunction. Variants of caveolin 3 (CAV3) play important roles in cardiovascular diseases. However, the potential roles of CAV3...
9.
Fang Q, Bai Y, Hu S, Ding J, Liu L, Dai M, et al.
Antioxidants (Basel)
. 2023 Nov;
12(11).
PMID: 38001831
Pulmonary vascular remodeling, characterized by the thickening of all three layers of the blood vessel wall, plays a central role in the pathogenesis of pulmonary hypertension (PH). Despite the approval...
10.
Zhuo C, Hu S, Chen G, Yang L, Cai Z, Tian H, et al.
Schizophrenia (Heidelb)
. 2023 Oct;
9(1):71.
PMID: 37838729
This study was conducted to investigate the effects of long-term low-dose lithium adjunct to antipsychotic agent use on the cognitive performance, whole-brain gray-matter volume (GMV), and interleukin-6 (IL-6) level in...